Agri Investment Fund

BiocSol focus on sustainable microbial-based crop protection.

Biotalys is an agricultural technology company based in Ghent, Belgium, founded in 2013. The company specializes in researching and developing biopesticides designed to control pests and diseases on crops and harvested products. Biotalys employs its proprietary Agrobody technology platform to create protein-based biocontrol solutions that combine the effectiveness of chemical pesticides with the safety profile of biologicals. These solutions are suitable for both pre- and post-harvest applications, aiming to provide a more sustainable and safer food supply. The company's technology platform generates products that enable targeted delivery and retention of active ingredients to prevent and control weeds, pests, and diseases.

Aphea.Bio is a company focused on developing next-generation biopesticides and biostimulants derived from natural microorganisms. Its biopesticides serve as an alternative to conventional chemical pesticides, addressing the increasing pressure on synthetic chemical use in agriculture. Additionally, the company creates biostimulants that enhance crop growth by improving the uptake of nutrients from the soil. Aphea.Bio's products aim to sustainably increase crop yields and health, specifically targeting crops such as maize and wheat. By utilizing proprietary technologies, the company accelerates the discovery of innovative biocontrol and biostimulant solutions, enabling farmers to manage pests, diseases, and fertilizer application more effectively.

Aphea.Bio is a company focused on developing next-generation biopesticides and biostimulants derived from natural microorganisms. Its biopesticides serve as an alternative to conventional chemical pesticides, addressing the increasing pressure on synthetic chemical use in agriculture. Additionally, the company creates biostimulants that enhance crop growth by improving the uptake of nutrients from the soil. Aphea.Bio's products aim to sustainably increase crop yields and health, specifically targeting crops such as maize and wheat. By utilizing proprietary technologies, the company accelerates the discovery of innovative biocontrol and biostimulant solutions, enabling farmers to manage pests, diseases, and fertilizer application more effectively.

Aphea.Bio is a company focused on developing next-generation biopesticides and biostimulants derived from natural microorganisms. Its biopesticides serve as an alternative to conventional chemical pesticides, addressing the increasing pressure on synthetic chemical use in agriculture. Additionally, the company creates biostimulants that enhance crop growth by improving the uptake of nutrients from the soil. Aphea.Bio's products aim to sustainably increase crop yields and health, specifically targeting crops such as maize and wheat. By utilizing proprietary technologies, the company accelerates the discovery of innovative biocontrol and biostimulant solutions, enabling farmers to manage pests, diseases, and fertilizer application more effectively.

Animab is a biotechnology company focused on enhancing livestock health through innovative solutions. The company specializes in developing monoclonal antibodies that mimic secretory IgA, a natural antibody found in colostrum and milk, to protect nursing animals. Animab's technology targets specific intestinal pathogens in livestock, particularly during the critical post-weaning stage for piglets, without disrupting the healthy microbiome. This approach aims to improve animal health, reduce costs, and promote sustainability in livestock production.

ViroVet is an innovative company focused on developing advanced technologies to combat viral diseases in livestock. Its product pipeline includes antiviral drugs targeting respiratory disease complexes and novel vaccines for swine viral infections. Given the substantial economic impact of viral diseases, which cost the livestock industry billions annually, ViroVet aims to provide effective solutions that can be used independently or alongside existing vaccines and biosecurity measures. The company addresses the growing demand for animal protein amid increasing global population and livestock density, as well as climate change challenges that heighten the risk of viral outbreaks. ViroVet has garnered support from key opinion leaders in livestock medicine, who recognize the potential of its products to transform the industry, notably by reducing antibiotic usage and enhancing overall animal health and productivity.

Biotalys is an agricultural technology company based in Ghent, Belgium, founded in 2013. The company specializes in researching and developing biopesticides designed to control pests and diseases on crops and harvested products. Biotalys employs its proprietary Agrobody technology platform to create protein-based biocontrol solutions that combine the effectiveness of chemical pesticides with the safety profile of biologicals. These solutions are suitable for both pre- and post-harvest applications, aiming to provide a more sustainable and safer food supply. The company's technology platform generates products that enable targeted delivery and retention of active ingredients to prevent and control weeds, pests, and diseases.

Aphea.Bio is a company focused on developing next-generation biopesticides and biostimulants derived from natural microorganisms. Its biopesticides serve as an alternative to conventional chemical pesticides, addressing the increasing pressure on synthetic chemical use in agriculture. Additionally, the company creates biostimulants that enhance crop growth by improving the uptake of nutrients from the soil. Aphea.Bio's products aim to sustainably increase crop yields and health, specifically targeting crops such as maize and wheat. By utilizing proprietary technologies, the company accelerates the discovery of innovative biocontrol and biostimulant solutions, enabling farmers to manage pests, diseases, and fertilizer application more effectively.

Okapi Sciences NV is a Belgium-based company focused on developing antiviral therapeutics specifically for pets and livestock. It has a proprietary platform that supports the creation of innovative treatments targeting various viral diseases. The company is advancing its pipeline of clinical and development stage candidates, including drugs intended for feline herpes and feline immunodeficiency virus. Through its research and development efforts, Okapi aims to provide veterinarians with the latest antiviral treatments, enhancing the standards of care for animal health. Targeting both companion animals and livestock, Okapi Sciences is positioned to make significant contributions to veterinary medicine with its novel technologies and strong academic partnerships.

Fugeia NV specializes in developing ingredients and nutrition technologies, focusing on arabinoxylan-oligosaccharides (AXOS), which offer various health benefits associated with wholegrain wheat. These benefits include potential prevention of lifestyle diseases such as diabetes, obesity, cardiovascular conditions, and cancer. The company has innovated technologies for prebiotic bread and AXOS-enriched beer, enhancing the levels of these beneficial compounds in these products. Fugeia's offerings cater to a wide range of market segments, including dairy and non-dairy beverages, ready-to-eat cereals, cookies, biscuits, bread, and pastries, as well as dietary supplements and therapeutics. Founded in 2008, the company is based in Heverlee, Belgium.